Exchange Traded Concepts, LLC Bristol Myers Squibb CO Transaction History

Exchange Traded Concepts, LLC

  • $4.18 Billion
  • Q3 2024

A detailed history of Exchange Traded Concepts, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 26,468 shares of BMY stock, worth $1.53 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
26,468
Previous 22,404 18.14%
Holding current value
$1.53 Million
Previous $930,000 47.2%
% of portfolio
0.03%
Previous 0.02%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024
BUY
$39.66 - $51.75 $161,178 - $210,312
4,064 Added 18.14%
26,468 $1.37 Million
Q2 2024

Aug 13, 2024
SELL
$40.25 - $52.99 $7,446 - $9,803
-185 Reduced 0.82%
22,404 $930,000
Q1 2024

Apr 15, 2024
SELL
$47.98 - $54.4 $287,927 - $326,454
-6,001 Reduced 20.99%
22,589 $1.23 Million
Q4 2023

Jan 05, 2024
SELL
$48.48 - $57.85 $16.5 Million - $19.7 Million
-341,185 Reduced 92.27%
28,590 $1.47 Million
Q3 2023

Oct 18, 2023
BUY
$57.89 - $64.73 $11.4 Million - $12.8 Million
197,106 Added 114.15%
369,775 $21.5 Million
Q2 2023

Jul 20, 2023
BUY
$63.71 - $70.74 $3.29 Million - $3.66 Million
51,682 Added 42.72%
172,669 $11 Million
Q1 2023

Apr 12, 2023
SELL
$65.71 - $74.53 $4.08 Million - $4.62 Million
-62,016 Reduced 33.89%
120,987 $8.39 Million
Q4 2022

Jan 17, 2023
SELL
$68.48 - $81.09 $419,303 - $496,514
-6,123 Reduced 3.24%
183,003 $13.2 Million
Q3 2022

Oct 07, 2022
BUY
$0.13 - $76.84 $11,181 - $6.61 Million
86,011 Added 83.41%
189,126 $13.4 Million
Q2 2022

Jul 20, 2022
SELL
$72.62 - $79.98 $547,700 - $603,209
-7,542 Reduced 6.82%
103,115 $7.94 Million
Q1 2022

Apr 26, 2022
BUY
$61.48 - $73.72 $4.2 Million - $5.04 Million
68,396 Added 161.84%
110,657 $8.08 Million
Q4 2021

Jan 13, 2022
SELL
$53.63 - $62.52 $11.7 Million - $13.6 Million
-217,899 Reduced 83.76%
42,261 $2.64 Million
Q3 2021

Oct 18, 2021
BUY
$59.17 - $69.31 $5.98 Million - $7 Million
101,055 Added 63.51%
260,160 $15.4 Million
Q2 2021

Jul 30, 2021
BUY
$61.91 - $67.42 $2.71 Million - $2.96 Million
43,840 Added 38.03%
159,105 $10.6 Million
Q1 2021

Apr 20, 2021
SELL
$59.34 - $66.74 $532,576 - $598,991
-8,975 Reduced 7.22%
115,265 $7.28 Million
Q4 2020

Jan 19, 2021
BUY
$57.74 - $65.43 $6.74 Million - $7.64 Million
116,713 Added 1550.59%
124,240 $7.71 Million
Q3 2020

Oct 30, 2020
BUY
$57.43 - $63.64 $210,595 - $233,367
3,667 Added 95.0%
7,527 $454,000
Q2 2020

Jul 15, 2020
SELL
$54.82 - $64.09 $2.05 Million - $2.4 Million
-37,482 Reduced 90.66%
3,860 $227,000
Q1 2020

Apr 14, 2020
BUY
$46.4 - $67.43 $1.38 Million - $2 Million
29,731 Added 256.06%
41,342 $2.3 Million
Q4 2019

Jan 22, 2020
BUY
$49.21 - $64.19 $571,377 - $745,310
11,611 New
11,611 $745,000

Others Institutions Holding BMY

# of Institutions
2,532
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Exchange Traded Concepts, LLC Portfolio

Follow Exchange Traded Concepts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email